Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 811 | 894 | 896 | 761 | 667 |
| Cost of Goods | 136 | 147 | 140 | 116 | 97 |
| Gross Profit | 676 | 747 | 756 | 645 | 570 |
| Operating Expenses | 2,912 | 2,612 | 3,191 | 2,228 | 2,318 |
| Operating Income | -2,100 | -1,718 | -2,295 | -1,467 | -1,651 |
| Interest Expense | 60 | 13 | 2 | 2 | 65 |
| Other Income | 37 | 41 | 19 | 21 | -39 |
| Pre-tax Income | -2,123 | -1,690 | -2,279 | -1,448 | -1,755 |
| Net Income Continuous | -2,123 | -1,690 | -2,279 | -1,448 | -1,755 |
| Net Income | $-2,123 | $-1,690 | $-2,279 | $-1,448 | $-1,755 |
| EPS Basic Total Ops | -0.24 | -0.22 | -0.33 | -0.23 | -0.25 |
| EPS Basic Continuous Ops | -0.21 | -0.20 | -0.31 | -0.20 | -0.24 |
| EPS Diluted Total Ops | -0.24 | -0.22 | -0.33 | -0.23 | -0.25 |
| EPS Diluted Continuous Ops | -0.21 | -0.20 | -0.31 | -0.20 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.24 | -0.22 | -0.31 | -0.21 | -0.25 |
| EBITDA(a) | $-2,084 | $-1,705 | $-2,289 | $-1,460 | $-1,601 |